For the Inventor, By the Inventor

Enter assignee name

Buenos Aires, Argentina

Gador S.a.

USPTO Granted Patents = 11

CIPO Patents = 3

EPO Patents = 3

Trademarks = 2

Forward Citations = 27

Loading Chart...

Loading Chart...

26 inventors (with patents filed for the assignee):

Rafael Alberto Labriola (5 out of 6 patents)

Dora Graciela Tombari (5 out of 5 patents)

Socrates Papapoulos (4 out of 4 patents)

4. Adriana Vechhioli (3 out of 3 patents)

5. Emilio J A Roldan (3 out of 4 patents)

6. Adriana Vecchioli (3 out of 3 patents)

7. Daniel Zanetti (2 out of 2 patents)

8. Damian Cairatti (2 out of 2 patents)

9. Enrique Piccinni (2 out of 2 patents)

10. Emilio Ja Roldan (2 out of 2 patents)

11. Constanza Pia Mangone (1 out of 1 patent)

12. Maria Beatriz Garcia (1 out of 1 patent)

13. Anibal Perez-Lloret (1 out of 2 patents)

14. Anibal Perez Lloret (1 out of 1 patent)

15. Clemens W Lowik (1 out of 1 patent)

11 patents: Sort by Forward Citations

1. 8952172 - Crystalline form of the zoledronic acid, a process to obtain it and the pharmaceutical composition comprising it (2015-02-10),

2. 8853187 - Composition comprising bisphosphonates for prevention and/or treatment of metabolic diseases of bones, process for preparing such composition and use thereof (2014-10-07),

3. 8338619 - Crystalline form of the zoledronic acid, a process to obtain it and the pharmaceutical composition comprising it (2012-12-25),

4. 8153648 - Solid and crystalline dutasteride and processes for preparation thereof (2012-04-10),

5. 7846474 - Use of bisphosphonates for the treatment of osteogenesis imperfecta (2010-12-07),

6. 7560490 - Composition comprising bisphosphonates for prevention and/or treatment of metabolic diseases of bones, process for preparing such composition and use thereof (2009-07-14),

7. 7345183 - Process for obtaining norelgestromin in different relations of isomers E and Z (2008-03-18),

8. 6864228 - Use of bisphosphonates for the treatment of osteogenesis imperfecta (2005-03-08),

9. 6476223 - Method for obtaining N-[3(3-cyano-pyrazole[1,5-a]pyrimidine-7-yl)phenyl]-N-ethyl-acetamide (2002-11-05),

10. 5990098 - Therapeutic use of (1999-11-23),

11. 5885973 - Bone mass anabolic composition comprising olpadronate (1999-03-23),

Gador S.A. is a pharmaceutical company based in Argentina, dedicated to the research, development and commercialization of high-quality pharmaceutical products. With a strong commitment to innovation and customer satisfaction, Gador offers a wide range of prescription and over-the-counter medications for various therapeutic areas.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

11 Patents

#4 in Buenos Aires

#8 in Argentina

#50,159 in the World

Buenos Aires, Argentina

Gador S.a.

Forward Citations = 27

26 inventors:

Rafael Alberto Labriola (5 out of 6 patents)

Dora Graciela Tombari (5 out of 5 patents)

Socrates Papapoulos (4 out of 4 patents)

4. Adriana Vechhioli (3 out of 3 patents)

5. Emilio J A Roldan (3 out of 4 patents)

Please report any incorrect information to support@idiyas.com

Loading…